Stefano Moro
Stefano Moro
Professor of Medicinal Chemistry
Verified email at - Homepage
TitleCited byYear
FAM/USP9x, a deubiquitinating enzyme essential for TGFβ signaling, controls Smad4 monoubiquitination
S Dupont, A Mamidi, M Cordenonsi, M Montagner, L Zacchigna, ...
Cell 136 (1), 123-135, 2009
Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery
S Vilar, G Cozza, S Moro
Current topics in medicinal chemistry 8 (18), 1555-1572, 2008
The mitochondrial calcium uniporter is a multimer that can include a dominant‐negative pore‐forming subunit
A Raffaello, D De Stefani, D Sabbadin, E Teardo, G Merli, A Picard, ...
The EMBO journal 32 (17), 2362-2376, 2013
Synthesis, CoMFA analysis, and receptor docking of 3, 5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists
AH Li, S Moro, N Forsyth, N Melman, X Ji, KA Jacobson
Journal of medicinal chemistry 42 (4), 706-721, 1999
DNA binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites
E Soldaini, S John, S Moro, J Bollenbacher, U Schindler, WJ Leonard
Molecular and cellular biology 20 (1), 389-401, 2000
Toward the rational design of protein kinase casein kinase-2 inhibitors
S Sarno, S Moro, F Meggio, G Zagotto, D Dal Ben, P Ghisellini, ...
Pharmacology & therapeutics 93 (2-3), 159-168, 2002
Human P2Y1 Receptor:  Molecular Modeling and Site-Directed Mutagenesis as Tools To Identify Agonist and Antagonist Recognition Sites
S Moro, D Guo, E Camaioni, JL Boyer, TK Harden, KA Jacobson
Journal of medicinal chemistry 41 (9), 1456-1466, 1998
Progress in the pursuit of therapeutic adenosine receptor antagonists
S Moro, ZG Gao, KA Jacobson, G Spalluto
Medicinal Research Reviews 26 (2), 131-159, 2006
USP15 is a deubiquitylating enzyme for receptor-activated SMADs
M Inui, A Manfrin, A Mamidi, G Martello, L Morsut, S Soligo, E Enzo, ...
Nature cell biology 13 (11), 1368-1375, 2011
The role of amino acids in extracellular loops of the human P2Y1 receptor in surface expression and activation processes
C Hoffmann, S Moro, RA Nicholas, TK Harden, KA Jacobson
Journal of Biological Chemistry 274 (21), 14639-14647, 1999
Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening application
G Cozza, P Bonvini, E Zorzi, G Poletto, MA Pagano, S Sarno, ...
Journal of medicinal chemistry 49 (8), 2363-2366, 2006
Structure−Activity Relationships and Molecular Modeling of 3,5-Diacyl-2,4-dialkylpyridine Derivatives as Selective A3 Adenosine Receptor Antagonists
AH Li, S Moro, N Melman, X Ji, KA Jacobson
Journal of medicinal chemistry 41 (17), 3186-3201, 1998
Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y1 receptor ligands
E Nandanan, SY Jang, S Moro, HO Kim, MA Siddiqui, P Russ, ...
Journal of medicinal chemistry 43 (5), 829-842, 2000
Hemolytic effects of water-soluble fullerene derivatives
S Bosi, L Feruglio, T Da Ros, G Spalluto, B Gregoretti, M Terdoslavich, ...
Journal of medicinal chemistry 47 (27), 6711-6715, 2004
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2
G Cozza, M Mazzorana, E Papinutto, J Bain, M Elliott, G Di Maira, ...
Biochemical Journal 421 (3), 387-395, 2009
Role of the Extracellular Loops of G Protein-Coupled Receptors in Ligand Recognition:  A Molecular Modeling Study of the Human P2Y1 Receptor
S Moro, C Hoffmann, KA Jacobson
Biochemistry 38 (12), 3498-3507, 1999
Synthesis, biological activity, and molecular modeling investigation of new pyrazolo [4, 3-e]-1, 2, 4-triazolo [1, 5-c] pyrimidine derivatives as human A3 adenosine receptor …
PG Baraldi, B Cacciari, S Moro, G Spalluto, G Pastorin, T Da Ros, ...
Journal of medicinal chemistry 45 (4), 770-780, 2002
Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes
YC Kim, M de Zwart, L Chang, S Moro, JK von Frijtag Drabbe Künzel, ...
Journal of medicinal chemistry 41 (15), 2835-2845, 1998
Toward efficient Zn (II)-based artificial nucleases
E Boseggia, M Gatos, L Lucatello, F Mancin, S Moro, M Palumbo, C Sissi, ...
Journal of the American Chemical Society 126 (14), 4543-4549, 2004
Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: an integrate approach to elucidate the putative binding motif and explain structure–activity relationships
A Chilin, R Battistutta, A Bortolato, G Cozza, S Zanatta, G Poletto, ...
Journal of medicinal chemistry 51 (4), 752-759, 2008
The system can't perform the operation now. Try again later.
Articles 1–20